Contact details

Submit a sales inquiry

Please provide some information below and we can help direct you to the right person

We work with partners and distributors who may contact you about this Philips product on our behalf.

Salutation

Academic title

First name*

Last name*

Email address*

Company*

Job title*

Specialty

Function

Department

City

Address

Zip or Postal Code

State or Province

Product of interest

Best time to call

Estimated time of purchase

Business phone

Comments

I want to be contacted by phone

What is cross border data transfer?

I agree on cross-border transfer of personal information.

I hereby agree to receive by email or telephone information about Philips products, services, events and promotions, including information by mail that is appropriate to me, taking into account my activities and preferences, including the Expectations I have indicated / and in this form.

I agree that Philips may share my personal information with authorized resellers of its Philips products and equipment in order to meet my expectations as stated in this form.

I would like to receive marketing related electronic communications about Philips products, services, events and promotions that may be relevant to me based on my user preferences and behavior. I can revoke my consent at any time.

Philips values and respects the personal information of its customers. You may revoke the permissions you grant at any time. See the Philips Privacy Policy for more information.

Les informations collectées sont enregistrées par Philips France Commercial, 33 rue de Verdun 92150 Suresnes. Vos données seront conservées en dehors de l’Union Européenne et utilisées par les services marketing de Philips pour une durée de 24 mois à compter de leur collecte ou du dernier contact de votre part.

Conformément à la loi n°78-17 Informatique et Libertés modifiée et au Règlement européen n° 2016/679 vous bénéficiez, sur les données personnelles qui vous concernent, d’un droit d’accès et de rectification et, s'ils sont applicables, d'un droit de suppression, d’opposition, d'effacement, de limitation du traitement, et de portabilité. Vous pouvez exercer ces droits en vous adressant à : privacy@philips.com en fournissant un justificatif d'identité. Vous pouvez également définir des directives relatives au sort de vos données après votre décès et introduire une réclamation auprès de la CNIL.

Sleep and respiratory

Article

Connect with us

Study suggests positive airway pressure therapy could reduce COPD patient hospitalization

However, 92% of the COPD patients studied did not receive PAP therapy

Hospitalization of patients with COPD creates a huge burden on the healthcare system―to the tune of an estimated $50 billion in associated costs^{1, 2}. And hospitalizations are at an all-time high – with the 30-day readmission rate for patients with chronic COPD ranging from 20-39%^3-5. A recent Philips-funded study revealed that while positive airway pressure (PAP) therapy was associated with a reduction in hospitalization, a staggering 92% of patients studied were not receiving it in any form.

The retrospective study led by Dr. Sairam Parthasarathy, professor of medicine and interim chief of Division of Pulmonary, Allergy, Critical Care and Sleep Medicine with University of Arizona College of Medicine, revealed that only 7.5 percent of some 1,881,652 COPD patients analyzed were receiving any form of PAP therapy.

There are multiple modes of PAP treatment which can be administered at home to help people alleviate symptoms of respiratory illness. The study reviewed administrative claims data suggesting that individuals receiving either Bi-level (BiPAP), continuous (CPAP) or noninvasive positive pressure ventilation (NIV) therapy in the home (n = 48,856) experienced lower hospitalization risk than before therapy initiation, as well as lower hospitalization risk than those who did not receive any positive airway pressure therapy at all.

“Frequent readmissions of COPD patients not only disrupt their quality of life, but are costing our health systems billions,” said Dr. Parthasarathy. “This analysis revealed that there is a solution already accessible within our toolbox that can keep patients out of the hospital, but it is significantly underutilized.”

Patients with multiple chronic medical conditions were analyzed as part of the study. Comorbidities such as sleep apnea, chronic respiratory failure and heart failure were associated with greater benefits from PAP therapy, though ultimately, results showed that further clinical study into a causal connection between PAP therapy and reduced hospital readmissions of COPD patients is indicated.

Noted Dr. Parthasarath: “With improved awareness and implementation of PAP therapy as a treatment for COPD, we can lower the cost burden for health systems while allowing patients to recover in the comfort of their own homes.”

“With improved awareness and implementation of PAP therapy … we can lower the cost burden for health systems while allowing patients to recover in the comfort of their own homes.”

-Dr. Sairam Parthasarathy,

Professor of medicine and interim chief of Division of Pulmonary, Allergy, Critical Care and Sleep Medicine with University of Arizona College of Medicine

Read the press release

¹American Lung Association. Trends in COPD (Chronic Bronchitis and Emphysema):Morbidity and Mortality. Available at: http://www.lung.org/assets/documents/research/copd-trend-report.pdf. ALA, 2013. Accessed November 23, 2016.

²American Lung Association. COPD Prevalence in Adults by State 2013. Available at: http://www.lung.org/lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html#Sources. Accessed November 23, 2016.

³Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med.2009;360:1418-1428.

⁴Chris K, Terra S, Andrew P. A propensity-matched retrospectiveanalysis to identify predictors of r hospitalization for patients with chronic obstructive pulmonary disease (COPD). C51. Hospitalization and readmission in chronic obstructive pulmonary disease: Am J Respir Crit Care Med. 2013;187:A4387.

⁵Elixhauser A, Au D, Podulka J. Readmissions for chronic obstructive pulmonary disease, 2008. HCUP Statistical Brief #121 (AHRQ) 2011; #121. Available at: https://www.hcup-us.ahrq.gov/reports/statbriefs/sb121.pdf. Accessed March 1, 2017.

Submit a sales inquiry

Stay up-to-date and subscribe

Sleep and respiratory

Article

Connect with us

Connect with us

Study suggests positive airway pressure therapy could reduce COPD patient hospitalization

However, 92% of the COPD patients studied did not receive PAP therapy